Neurotrophic Keratitis

被引：84

作者：

Semeraro, F. ^{[1
]}

Forbice, E. ^{[1
]}

Romano, V. ^{[2
]}

Angi, M. ^{[2
]}

Romano, M. R. ^{[2
,3
]}

Filippelli, M. E. ^{[2
]}

Di Iorio, R. ^{[2
]}

Costagliola, C. ^{[2
]}

机构：

[1] Univ Brescia, Dept Ophthalmol, Eye Clin, IT-25100 Brescia, Italy

[2] Univ Molise, Dept Hlth Sci, Eye Clin, Campobasso, Italy

[3] Ist Clin Humanitas, Eye Unit, Rozzano, Italy

来源：

OPHTHALMOLOGICA | 2014年 / 231卷 / 04期

关键词：

Neurotrophic keratitis; Corneal sensitivity; Trigeminal nerve; Corneal vascularization; Stromal ulcers; NERVE GROWTH-FACTOR; PERSISTENT EPITHELIAL DEFECTS; AMNIOTIC MEMBRANE TRANSPLANTATION; AUTOLOGOUS SERUM APPLICATION; SCLERAL CONTACT-LENSES; IN-VITRO TOXICITY; SEVERE DRY EYE; SUBSTANCE-P; PENETRATING KERATOPLASTY; CORNEAL SENSITIVITY;

D O I：

10.1159/000354380

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Neurotrophic keratitis (NK) is a rare degenerative corneal disease that occurs as a result of partial or total impairment of trigeminal innervations, leading to a reduction (hypoesthesia) in or loss (anaesthesia) of corneal sensitivity. The impairment of sensory innervation causes a reduction in the lacrimation reflex and the vitality, metabolism and mitosis of epithelial cells, with subsequent deficiency in epithelial repair, stromal and intracellular oedema, loss of microvilli, and abnormal development of the basal lamina. Several recent studies have proposed different therapies based on different aetiopathogenetic theories. The aim of the therapy is to treat aetiopathogenesis and, at the same time, promote corneal healing. In this paper, we report the aetiology, diagnosis, management, and medical and surgical treatment of NK, also indicating future treatments based on the most recent studies. (c) 2013 S. Karger AG, Basel

引用

页码：191 / 197

页数：7

共 50 条

[31] Nerve Growth Factor of Patients with neurotrophic Keratitis
不详
OPHTHALMOLOGE, 2019, 116 (11): : 1007 - 1007
[32] New Pharmacological Approaches for the Treatment of Neurotrophic Keratitis
Koay, Su Yin
Larkin, Daniel F. P.
FRONTIERS IN PHARMACOLOGY, 2022, 13
[33] Neurotrophic keratitis in a patient with dihydroxypyrimidine dehydrogenase deficiency
Kapoor, Bharat
Luhishi, Ezzedin A.
Chung, Andrew K. K.
Pauw, Jakobus C.
INDIAN JOURNAL OF OPHTHALMOLOGY, 2008, 56 (04) : 336 - 337
[34] Neurotrophic keratitis as a peripheral sensory neurodegenerative disease
Aracil, Adolfo
ACTA OPHTHALMOLOGICA, 2019, 97
[35] Neurotrophic keratitis secondary to cavernous sinus thrombosis
El Bouaychi, A.
Boudguigue, F.
Ridallah, A.
Cherkaoui, O.
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2020, 43 (07): : 660 - 662
[36] Central isolated band keratopathy and neurotrophic keratitis
Row, PK
Affeldt, JC
Agarwal, MR
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U638 - U638
[37] Neurotrophic keratitis in hereditary sensory autonomic neuropathy
Lomi, Neiwete
Rani, Deeksha
NATIONAL MEDICAL JOURNAL OF INDIA, 2021, 34 (05): : 316 - 316
[38] Neurotrophic keratitis: inflammatory pathogenesis and novel therapies
Wajnsztajn, Denise
Faraj, Lana A.
Sanchez-Tabernero, Sara
Solomon, Abraham
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 23 (06) : 520 - 528
[39] Neurotrophic keratitis: current challenges and future prospects
Versura, Piera
Giannaccare, Giuseppe
Pellegrini, Marco
Sebastiani, Stefano
Campos, Emilio C.
EYE AND BRAIN, 2018, 10 : 37 - 45
[40] Semaphorin 7a in Herpetic Neurotrophic Keratitis
Shukla, Deepak
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (02) : 1108 - 1108

← 1 2 3 4 5 →